Medical Innovation - June 2022 Archives

Patients treated with monoclonal antibodies during COVID-19 delta surge had low rates of severe disease, Mayo Clinic study finds

ROCHESTER, Minn. — A study of 10,775 high-risk adult patients during the COVID-19 delta variant surge in late 2021 finds that treatment with one of ...

By Jay Furst • June 27, 2022

Scientists unravel genetic mystery of rare neurodevelopmental disorder, provide definitive diagnoses to 21 families worldwide

ROCHESTER, Minn. — A collaborative team of scientists led by Mayo Clinic's Center for Individualized Medicine has discovered 15 additional genetic mutations in the KCNK9 ...

By Susan Murphy • June 21, 2022

Coronary artery bypass grafting has potential benefits for patients over age 80 with reasonable surgical risk, Mayo Clinic study finds

ROCHESTER, Minn. — Patients over age 80 are considered high-risk candidates for coronary artery bypass grafting, not only because of normal wear and tear on ...

By Jay Furst • June 20, 2022

Science Saturday: Study indicates gut microbiome, host gene affect gastrointestinal disorders

In a new study published in Nature Microbiology, researchers demonstrated the power of integrating the microbiome and host gene expression data to provide insights into their ...

By Colette Gallagher • June 18, 2022

Science Saturday: Link found between key gene and two neurodegenerative diseases

Gene expression can amplify the risk of neurodegenerative diseases for patients, but researchers are still figuring out which genes have an outsized effect on risk ...

By Lynda De Widt • June 11, 2022

Patients with mitral annulus calcification at higher risk of heart valve and cardiovascular disease, Mayo Clinic research finds

ROCHESTER, Minn. — A retrospective review of more than 24,000 patients who underwent an echocardiogram at Mayo Clinic finds that nearly one-quarter of the patients ...

By Jay Furst • June 1, 2022